Boston Common Asset Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.47M Sell
38,377
-1,140
-3% -$315K 0.5% 60
2026
Q1
$11.7M Sell
39,517
-1,270
-3% -$377K 0.75% 42
2025
Q4
$11.1M Sell
40,787
-12,022
-23% -$3.27M 0.67% 45
2025
Q3
$14.3M Buy
52,809
+3,211
+6% +$874K 0.4% 90
2025
Q2
$13.7M Buy
49,598
+17,222
+53% +$4.68M 0.38% 93
2025
Q1
$8.59M Sell
32,376
-870
-3% -$215K 0.26% 134
2024
Q4
$7.72M Sell
33,246
-1,916
-5% -$441K 0.22% 141
2024
Q3
$7.76M Sell
35,162
-480
-1% -$99.3K 0.2% 154
2024
Q2
$7.01M Buy
35,642
+391
+1% +$80.8K 0.18% 156
2024
Q1
$7.59M Sell
35,251
-1,008
-3% -$212K 0.18% 158
2023
Q4
$7.64M Sell
36,259
-8,163
-18% -$1.74M 0.17% 159
2023
Q3
$8.89M Sell
44,422
-378
-0.8% -$75.1K 0.21% 152
2023
Q2
$8.3M Sell
44,800
-2,551
-5% -$471K 0.18% 157
2023
Q1
$9.07M Buy
47,351
+66
+0.1% +$11.9K 0.19% 157
2022
Q4
$7.95M Buy
47,285
+14,300
+43% +$2.49M 0.38% 88
2022
Q3
$5.84M Buy
32,985
+10,586
+47% +$2.09M 0.31% 99
2022
Q2
$4.58M Sell
22,399
-340
-1% -$72.1K 0.23% 112
2022
Q1
$5.41M Buy
22,739
+309
+1% +$72.6K 0.23% 110
2021
Q4
$5.12M Sell
22,430
-813
-3% -$179K 0.21% 113
2021
Q3
$4.5M Sell
23,243
-377
-2% -$76.4K 0.19% 118
2021
Q2
$5.02M Buy
23,620
+113
+0.5% +$23.9K 0.22% 110
2021
Q1
$4.8M Sell
23,507
-95
-0.4% -$18.7K 0.3% 96
2020
Q4
$4.3M Sell
23,602
-48
-0.2% -$8.16K 0.3% 96
2020
Q3
$3.96M Sell
23,650
-316
-1% -$53.2K 0.38% 78
2020
Q2
$3.9M Sell
23,966
-556
-2% -$99.7K 0.42% 70
2020
Q1
$4.24M Buy
24,522
+5,301
+28% +$1.06M 0.6% 58
2019
Q4
$3.86M Sell
19,221
-12,678
-40% -$2.6M 0.45% 73
2019
Q3
$6.74M Sell
31,899
-14,811
-32% -$3.09M 0.83% 44
2019
Q2
$9.07M Buy
46,710
+10,093
+28% +$1.86M 1.13% 23
2019
Q1
$6.03M Buy
36,617
+13,142
+56% +$2.32M 0.78% 46
2018
Q4
$4.42M Sell
23,475
-25,994
-53% -$4.8M 0.64% 59
2018
Q3
$8.42M Sell
49,469
-3,138
-6% -$528K 1.04% 21
2018
Q2
$8.62M Sell
52,607
-397
-0.7% -$64.8K 1.07% 24
2018
Q1
$8.57M Sell
53,004
-3,855
-7% -$614K 1.01% 25
2017
Q4
$8.3M Buy
56,859
+2,918
+5% +$416K 0.99% 29
2017
Q3
$7.32M Buy
53,941
+305
+0.6% +$38.5K 0.91% 31
2017
Q2
$6.72M Sell
53,636
-4,402
-8% -$526K 0.88% 33
2017
Q1
$6.89M Sell
58,038
-11,822
-17% -$1.42M 0.94% 29
2016
Q4
$8.06M Buy
69,860
+455
+0.7% +$50.6K 1.18% 20
2016
Q3
$7.25M Sell
69,405
-11,382
-14% -$1.19M 0.39% 87
2016
Q2
$7.87M Sell
80,787
-145
-0.2% -$13.7K 0.45% 82
2016
Q1
$7.77M Sell
80,932
-735
-0.9% -$66.9K 0.44% 81
2015
Q4
$7.4M Sell
81,667
-3,595
-4% -$338K 0.42% 84
2015
Q3
$7.91M Buy
85,262
+1,460
+2% +$139K 0.48% 79
2015
Q2
$7.8M Sell
83,802
-1,940
-2% -$181K 0.41% 87
2015
Q1
$8.12M Buy
85,742
+935
+1% +$86.6K 0.43% 84
2014
Q4
$7.52M Buy
84,807
+105
+0.1% +$8.9K 0.42% 91
2014
Q3
$6.77M Buy
84,702
+22,572
+36% +$1.7M 0.38% 99
2014
Q2
$4.41M Buy
62,130
+58
+0.1% +$4.08K 0.24% 128
2014
Q1
$4.59M Buy
62,072
+745
+1% +$56.2K 0.26% 123
2013
Q4
$4.81M Sell
61,327
-10,481
-15% -$821K 0.27% 122
2013
Q3
$5.3M Buy
71,808
+39,245
+121% +$2.89M 0.31% 117
2013
Q2
$2.47M Buy
+32,563
New +$2.14M 0.15% 156

Other funds holding CME

Boston Common Asset Management's CME Position: Q2 2026 in Review

Boston Common Asset Management reduced its CME Group (CME) stake by 2.9% in Q2 2026, selling an estimated $315K and leaving 38,377 shares worth $8.47M. The position accounts for 0.5% of the portfolio, ranked #60.

Boston Common Asset Management first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.3M in Q3 2025. 439 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Boston Common Asset Management held 38,377 shares of CME Group worth $8.47M as of Q2 2026.
  • Boston Common Asset Management sold 1,140 CME Group shares in Q2 2026, an estimated $315K.
  • CME Group made up 0.5% of Boston Common Asset Management's portfolio in Q2 2026, its #60 holding.
  • Boston Common Asset Management first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
  • Boston Common Asset Management's CME Group position peaked at $14.3M in Q3 2025.
  • 439 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Boston Common Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.